Plus, retail sales jumped a record 17.7% in May, a sturdy from the University of Oxford showed a common anti-inflammatory drug proves to save lives among those sickest with COVID-19, and McDonald’s shares are slightly higher on improved sales in May.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, Treasury Secretary Mnuchin said “we can’t shut down the economy again” for a second wave, weekly jobless claims came in at more than 1.5 million, and Regeneron said it started the first clinical trial of its coronavirus antibody treatment.
Read MorePlus, the OECD warned that the coronavirus has caused the worst recession outside wartime in 100 years, Starbucks expects to lose $3.2 billion in revenue in its fiscal third quarter, and Taubman shares are down more than -20% after Simon Property Group said it is terminating its deal to acquire the luxury mall owner.
Read MoreTrade Setup Buy Target $1.06 Sell Target $1.33 NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, […]
Read MoreBuy Price: $15.00 or better Sell Price: TradersPro Sell Signal Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies using protein design technology. The company’s lead product candidate is NL-201, a computationally-designed de novo protein therapeutic for the treatment of IL-2/IL-15 cancer immunotherapy. It also engages in research activities for the treatment of autoimmunity and allergy
Read MorePlus, Congressional Democrats unveiled a new bill to overhaul police practices in the U.S., the next coronavirus stimulus bill may depend on June’s jobs report, and Beyond Meat shares are rising after the alternative meat producer landed a distribution deal in China.
Read MoreThese 2 stocks look like they’re headed for more upside.
Read MorePlus, weekly jobless claims came in at 1.877 million, the FDA issued emergency use authorization for Roche’s blood test to identify those at risk of having the most severe immunological response to the coronavirus, and Simon Property Group is suing Gap for missed rent.
Read MoreStarting into a new month, a lot of analysts right now seem to be turning more optimistic. The last two months have seen a rally in the broad market indices that has a lot of people starting to talk about how much of the February-to-March drop to bear market conditions stocks have reclaimed. How much […]
Read MorePlus, health officials warned the protests could exacerbate the coronavirus outbreak in vulnerable communities, China suspended purchases of some U.S. agricultural products amid growing tensions, and Tesla shares are up after the successful SpaceX launch this weekend.
Read MorePlus, another 2.1 million Americans applied for unemployment benefits last week, Trump is expected to sign an executive order to crack down on liability protections for social media platforms, and Abercrombie shares are down after the mall-staple reported a 34% drop in sales in the first quarter.
Read MorePlus, the U.S. is stepping up pressure on China, the EU unveiled an unprecedented stimulus plan, and Boeing plans to lay off more than 6,000 workers this week.
Read MorePlus, stocks are higher on optimism related to increased economic activity as economies continue to reopen, Autozone reported better-than-expected earnings, and Micron shares are up after an upgrade from Needham.
Read More